Recruitment completed in trial to evaluate the optimal dosing frequency for Zealand's long-acting GLP-2 analog glepaglutide https://www.globenewswire.com/news-release/2017/11/14/1185602/0/en/Recruitment-completed-in-trial-to-evaluate-the-optimal-dosing-frequency-for-Zealand-s-long-acting-GLP-2-analog-glepaglutide.html press release